Gergely; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gergely; Peter.The latest application filed is for "treatment of hematopoietic stem cell transplant patients".

Company Profile

3.3.19

Gergely; Peter - Oberwil CH
GERGELY; Peter - Basel CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment of graft versus host disease in transplant patients Grant 11,224,604 - Gergely , et al. January 18, 2	2022-01-18
Treatment Of Hematopoietic Stem Cell Transplant Patients App 20210346317 - BUCHER; Christoph ; et al.	2021-11-11
Agent For Inhibiting Recurrence Of Hematological Malignancy In Patients Who Have Undergone Hematopoietic Stem Cell Transplantation App 20210283073 - CORRADO; Claudia ; et al.	2021-09-16
Wnt Inhibitors For Use In The Treatment Of Fibrosis App 20200306244 - HARRIS; Jennifer Leslie ; et al.	2020-10-01
Anti-CD40 Antibodies for Use in Treatment of Sjogren's Syndrome App 20190153111 - Espie; Pascal ; et al.	2019-05-23
Treatment Of Hematopoietic Stem Cell Transplant Patients App 20190022033 - BUCHER; Christoph ; et al.	2019-01-24
Dosage Regimen of Diaryl Sulfide Derivatives App 20180161290 - Gergely; Peter ; et al.	2018-06-14
Treatment Of Graft Versus Host Disease In Transplant Patients App 20180153911 - Gergely; Peter ; et al.	2018-06-07
Dosage Regimen of Diaryl Sulfide Derivatives App 20170119702 - Gergely; Peter ; et al.	2017-05-04
Sphingosine 1 Phosphate Receptor Moduators And Their Use To Treat Muscle Inflammation App 20160175282 - LONDEL; Marco ; et al.	2016-06-23
Treatment Of Graft Versus Host Disease In Transplant Patients App 20160000811 - GERGELY; Peter ; et al.	2016-01-07
Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation Grant 9,149,459 - Ahmed , et al. October 6, 2	2015-10-06
Dosage Regimen of Diaryl Sulfide Derivatives App 20140336265 - Gergely; Peter ; et al.	2014-11-13
Dosage Regimen of Diaryl Sulfide Derivatives App 20130210924 - Gergely; Peter ; et al.	2013-08-15
Treatment of Autoimmune Diseases App 20130172297 - Gergely; Peter ; et al.	2013-07-04
Sphingosine 1 Phosphate Receptor Moduators And Their Use To Treat Muscle Inflammation App 20110124620 - Ahmed; Syed Sohail ; et al.	2011-05-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.